TP53 and cancer: However, mutant p53 can actually promote cancer progression by allowing cells to bypass senescence and even drive metastasis, while sometimes paradoxically inducing a detrimental, pro-tumorigenic senescence (SASP) in tumors, especially after chemotherapy, leading to resistance and relapse [51,52].